Skip to main navigation
Main navigation
About
Who We Are
Management
Board of Directors
Scientific Advisory Board
Pipeline
Therapeutic Areas
Gorlin Syndrome
Pachyonychia Congenita
Acne Vulgaris
Inflammatory Lesions of Rosacea
Investors
Investor Overview
Press Releases
Events & Presentations
Corporate Governance
Analyst Coverage
Financial Information
Proxy Statements
Stock Information
Shareholder Services
Media
Contact
Proxy Statements
Sol-Gel Proxy Statement March 2023
1.4 MB
Shareholder Tools
Print
Print
Email Alerts
Email Alerts
RSS Feeds
RSS Feeds